EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Metabolomics Reveals a Potential Benefit of Methionine in Type 1 Diabetes Patients with Poor Glycemic Control and High Glycemic Variability

Liyin Zhang iD, Keyu Guo, Qi Tian, Jianan Ye, Zhiyi Ding, Qin Zhou, Xia Li, Zhiguang Zhou iD, Lin Yang

Nutrients · 19.01.2023 · 15 (3) · 518

DOI: 10.3390/nu15030518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 19.01.2023. Verfasst von Liyin Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Hyperglycemia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycemic variability (GV) in some patients with type 1 diabetes (T1D) remains heterogeneous despite comparable clinical indicators, and whether other factors are involved is yet unknown. Metabolites in the serum indicate a broad effect of GV on cellular metabolism and therefore are more likely to indicate metabolic dysregulation associated with T1D. To compare the metabolomic profiles between high GV (GV-H, coefficient of variation (CV) of glucose ≥ 36%) and low GV (GV-L, CV < 36%) groups and to identify potential GV biomarkers, metabolomics profiling was carried out on serum samples from 17 patients with high GV, 16 matched (for age, sex, body mass index (BMI), diabetes duration, insulin dose, glycated hemoglobin (HbA1c), fasting, and 2 h postprandial C-peptide) patients with low GV (exploratory set), and another 21 (GV-H/GV-L: 11/10) matched patients (validation set). Subsequently, 25 metabolites were significantly enriched in seven Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways between the GV-H and GV-L groups in the exploratory set. Only the differences in spermidine, L-methionine, and trehalose remained significant after validation. The area under the curve of these three metabolites combined in distinguishing GV-H from GV-L was 0.952 and 0.918 in the exploratory and validation sets, respectively. L-methionine was significantly inversely related to HbA1c and glucose CV, while spermidine was significantly positively associated with glucose CV. Differences in trehalose were not as reliable as those in spermidine and L-methionine because of the relatively low amounts of trehalose and the inconsistent fold change sizes in the exploratory and validation sets. Our findings suggest that metabolomic disturbances may impact the GV of T1D. Additional in vitro and in vivo mechanistic studies are required to elucidate the relationship between spermidine and L-methionine levels and GV in T1D patients with different geographical and nutritional backgrounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1HyperglycemiaHumansGlycated HemoglobinBlood GlucoseMethionineGlycemic ControlSpermidineTrehaloseRacemethionineGlucose

Stichwörter der Autor:innen

continuous glucose monitoringglycemic variabilitymetabolomicstype 1 diabetes

Substanzen

Glycated HemoglobinBlood GlucoseMethionineSpermidineTrehaloseRacemethionineGlucose

Autor:innen und Institutionen

  • National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University…

ORCID-Profile: Liyin Zhang, Zhiguang Zhou

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • National Key R&amp;D Program of China

Zitieren

APA

Zhang, L., Guo, K., Tian, Q., Ye, J., Ding, Z., Zhou, Q., Li, X., Zhou, Z., & Yang, L. (2023). Serum Metabolomics Reveals a Potential Benefit of Methionine in Type 1 Diabetes Patients with Poor Glycemic Control and High Glycemic Variability. Nutrients, 15(3), 518. https://doi.org/10.3390/nu15030518

Vancouver

Zhang L, Guo K, Tian Q, Ye J, Ding Z, Zhou Q, et al. Serum Metabolomics Reveals a Potential Benefit of Methionine in Type 1 Diabetes Patients with Poor Glycemic Control and High Glycemic Variability. Nutrients. 2023;15(3):518. doi:10.3390/nu15030518

BibTeX
@article{Zhang2023,
  author = {Zhang, Liyin and Guo, Keyu and Tian, Qi and Ye, Jianan and Ding, Zhiyi and Zhou, Qin and Li, Xia and Zhou, Zhiguang and Yang, Lin},
  title = {Serum Metabolomics Reveals a Potential Benefit of Methionine in Type 1 Diabetes Patients with Poor Glycemic Control and High Glycemic Variability},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {518},
  doi = {10.3390/nu15030518}
}
Kostenlos starten →